Kadmon Holdings, Inc. KDMN

Kadmon Holdings, Inc. DPO Ratio 2011-2026 | KDMN

Annual DPO Ratio Kadmon Holdings, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.99 K	2.56 K	5.34 K	979	594	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
5.34 K	594	2.29 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Alnylam Pharmaceuticals ALNY	55	$ 330.34	3.6 %	$ 43.3 B	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Aquestive Therapeutics AQST	395	$ 4.09	-0.97 %	$ 437 M	USA
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
Celldex Therapeutics CLDX	4.06 K	$ 31.37	1.0 %	$ 2.08 B	USA
Arcutis Biotherapeutics ARQT	133	$ 23.66	0.11 %	$ 3.01 B	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	182	-	-	$ 546 M	USA
Brickell Biotech BBI	105	-	-5.38 %	$ 6.06 M	USA
Ardelyx ARDX	163	$ 5.97	0.51 %	$ 1.44 B	USA
CASI Pharmaceuticals CASI	123	-	-	$ 35.4 M	USA
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA